Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
LymphomaMultiple MyelomaLeukemiaMyelodysplastic Syndrome
Interventions
DRUG

Busulfan, Fludarabine, Cytoxan

"Busulfan once a day for 4 days~Fludarabine once a day for 4 days~Bone marrow transplant~Cytoxan two doses"

Trial Locations (3)

21231

The Sydney Kimmel Comprehensive Cancer center, Baltimore

77030

Marcos deLima, MD, Houston

98109

Paul V. O'Donnell, M.D., Ph.D., Seattle

Sponsors
All Listed Sponsors
collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Fred Hutchinson Cancer Center

OTHER

collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER